TrialAnnals of surgical oncology2024

Induction Therapy of Tislelizumab Combined with Cisplatin and 5-Fluorouracil and Subsequent Conversion Surgery in Patients with Unresectable Advanced Esophageal Squamous Cell Carcinoma: A Phase 2, Single Center Study.

Tongpeng Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.